Filing Details
- Accession Number:
- 0000899243-21-003455
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-27 12:18:58
- Reporting Period:
- 2021-01-25
- Accepted Time:
- 2021-01-27 12:18:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1444307 | Oncosec Medical Inc | ONCS | Pharmaceutical Preparations (2834) | 980573252 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1802483 | Sirtex Medical Us Holdings, Inc. | 300 Unicorn Park Drive Woburn MA 01801 | No | No | Yes | Yes | |
1802574 | Ltd Holdings Healthcare & Pharmaceutical Grand China | C/O Chao Zhou, Unit 3302, 33/F, The Center, 99 Queen'S Road Central Hong Kong | No | No | Yes | No | |
1803972 | Ltd Developments Decade Grand | C/O Chao Zhou, Unit 3302, 33/F, The Center, 99 Queen'S Road Central Hong Kong | No | No | Yes | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-01-25 | 3,389,198 | $5.45 | 15,388,198 | No | 4 | P | Indirect | See Footnote |
Common Stock | Acquisiton | 2021-01-25 | 677,839 | $5.45 | 3,077,639 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnote |
No | 4 | P | Indirect | See Footnote |
Footnotes
- Securities held by Grand Decade Developments Limited, a wholly owned subsidiary of the Reporting Person.
- Securities held by Sirtex Medical US Holdings, Inc., an affiliate of the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.